Carrington to sell products in Italy through Recordati:
This article was originally published in Clinica
Executive Summary
Carrington Laboratories, a woundcare company, has signed a 10- year distribution and marketing agreement with the Italian company Recordati Chemical and Pharmaceutical. Recordati, which is to sell Carrington's woundcare and oral products in Italy, will register Carrington's products for sale and reimbursement in Italy. The company is to pay a six-figure amount for the rights within 30 days, with two further, similar payments due when milestones are reached. Carrington is to pursue CE-marking for its products.